Abstract
The inclusion of the human mobility aspect is essential for understanding the behavior of COVID-19 spread, especially when millions of people travel across borders near Eid Al-Fitr. This study aims at grasping the effect of mass exodus among regions on the active cases of COVID-19 in a mathematical perspective. We construct a multi-region SIQRD (Susceptible-Infected-Quarantined-Recovered-Death) model that accommodates the direct transfer of people from one region to others. The mobility rate is estimated using the proposed Dawson-like function, which requires the Origin-Destination Matrix data. Assuming only susceptible, unapparent infected, and recovered individuals travel near Eid Al-Fitr, the rendered model is well-depicting the actual data at that time, giving either a significant spike or decline in the number of active cases due to the mass exodus. Most agglomerated regions like Jakarta and Depok City experienced the fall of active cases number, both in actual data and the simulated model. However, most rural areas experienced the opposite, like Bandung District and Cimahi City. This study should confirm that most travelers originated from big cities to the rural regions and scientifically justifies that massive mobility affects the COVID-19 transmission among areas.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partly funded by the Ministry of Transportation R&D 2021.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only openly available human data, which can be obtained from: https://kawalcovid19.id/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Email: kamalkhairudin{at}students.itb.ac.id
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos